MARKETS / NYSE / AMN
NYSE · SERVICES-HELP SUPPLY SERVICES · LARGE CAP

AMN Healthcare Services, Inc. AMN

17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$2.7B
▼ 8.5% vs FY2024
EPS · FY25
$-2.48
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-14.2%
Net margin · FY25
-3.5%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 2.7B
Revenue, FY2025 · full 17-year series below
Revenue Net income
2462.7-0.12009201220152018202120242025
2462.7-0.12016201920222025

The company lost 4 cents on every revenue dollar this year.

Per share
USD -2.48
Diluted EPS, FY2025
EPS
4812-2.482009201220152018202120242025
4812-2.482016201920222025

The company pays no cash dividend.

Profitability
-14.2%
Return on equity, FY2025
ROE
204060-14.2%2009201220152018202120242025
204060-14.2%2016201920222025
Operating margin-2.0%
Net margin-3.5%
Return on assets-4.2%

Each USD of equity lost 14 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacksUSD 0.00
Share of profit-0.0%
Consecutive raises

Growth
+2.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−19.5%
+2.7%
+6.4%
+9.8%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.04B
Shares outstanding, FY2025
0.040.042009201220152018202120242025
0.050.042016201920222025
Change, 5 years−18.3%
Change, 10 years−19.4%

The share count shrank 18% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.1B
total assets, end of FY2025
Total assetsUSD 2.1B
EquityUSD 642.1M
CashUSD 34.0M
Gross debtUSD 767.1M
Net debtUSD 733.1M
Current ratio0.94×

Net debt stands at 114% of equity.

History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
2.7
3.0
3.8
5.2
4.0
2.4
2.2
2.1
2.0
1.9
1.5
1.0
1.0
1.0
0.9
0.7
0.8
Operating income $B
−0.1
−0.1
0.3
0.6
0.5
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.0
−0.0
−0.2
EBITDA $B
0.1
0.1
0.5
0.8
0.6
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
−0.0
−0.1
Income tax $B
−0.0
−0.0
0.1
0.2
0.1
0.0
0.0
0.0
0.1
0.1
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
Net income $B
−0.1
−0.1
0.2
0.4
0.3
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
0.0
−0.0
−0.1
−0.1
EPS, diluted $
−2.48
−3.85
5.36
9.90
6.81
1.48
2.40
2.91
2.68
2.15
1.68
0.69
0.69
0.37
−0.57
−1.49
−3.75
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−14.2
−19.1
22.5
40.3
33.0
9.1
16.6
23.6
26.2
26.6
27.1
14.0
16.5
10.8
−18.2
−32.1
−71.5
Shares out B
0.04
0.04
0.04
0.04
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.04
0.04
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed